Introduction
============

Social synchrony, or the temporal concordance of behavioral and physiological processes among individuals, is thought to confer evolutionary advantages in various social species. For example, groups of insects, birds and fish synchronize their moves and speeds, a social phenomenon called swarming, flocking, schooling or herding ([@nsx061-B76]). In humans, social synchrony has been documented across a wide range of settings and contexts, ranging from choir singing during mass to the concerted behavior of stock market traders ([@nsx061-B76]). Current anthropological and psychological perspectives on social synchrony emphasize the strengthening of group cohesion and synergy, which may underlie collective intelligence ([@nsx061-B75]). Furthermore, social synchrony may be central to the development of affiliative bonds, including maternal and partner bonds ([@nsx061-B25]; [@nsx061-B6]). While the evolutionary benefits of social synchrony may be most prominent in the reproductive domain, it appears that synchronized action can ease interpersonal communication and collaboration more generally. For instance, synchronizing one's body movements with those of another person during dyadic interactions elicits a broad range of positive interpersonal behaviors in the imitated person, such as generosity ([@nsx061-B70]), rapport ([@nsx061-B11]), feelings of closeness ([@nsx061-B14]), cooperation ([@nsx061-B36]) and affiliation ([@nsx061-B30]; [@nsx061-B13]). Moreover, therapeutic interventions aiming at refined kinesthetic synchronization are believed to foster emotional empathic processes ([@nsx061-B38]; [@nsx061-B10]). Likewise, interpersonal coordination in body movement during psychotherapy sessions reflects the emotional quality of the therapeutic relationship ([@nsx061-B54]). Thus, interpersonal synchronization at the sensorimotor level seems to be closely linked to processes of cognitive (e.g. social conformity) and emotional alignment (e.g. emotional contagion) with others. Consistent with this notion, evidence from neuroimaging studies suggests that social synchrony is orchestrated by the interplay of various brain regions involved in the detection and sharing of emotions and mind states ([@nsx061-B6]). Yet, the neuroendocrine substrates of social synchrony and the neurobiological mechanisms translating social synchrony into refined socio-cognitive information transmission have received limited attention.

In recent years, the hypothalamic peptide oxytocin (OXT) has been identified as a key modulator of social group living and emotional processing. A plethora of human intranasal studies have emphasized OXT's involvement in various forms of higher order interpersonal behaviors such as cooperation ([@nsx061-B18]), trust ([@nsx061-B40]; [@nsx061-B8]) and romantic relationships ([@nsx061-B57]; [@nsx061-B59]; [@nsx061-B31]). Intriguingly, there is converging evidence from studies in non-human and human primates that both receiving OXT and experiencing synchrony (i.e. being imitated by an interacting partner) yield similar behavioral and neural outcomes ([@nsx061-B64]; [@nsx061-B51]; [@nsx061-B3]; [@nsx061-B28]; [@nsx061-B2]; [@nsx061-B27]). For example, exogenous OXT increases infant macaques' affiliative gestures towards a human caregiver, and peripheral OXT levels positively correlate with the time spent in close proximity to the caregiver ([@nsx061-B64]). Likewise, capuchin monkeys show a visual preference for and spend more time in proximity to caregivers who imitate them compared with an equally familiar, non-imitating partner ([@nsx061-B51]).

In fact, [@nsx061-B4] have put forward the hypothesis that 'being imitated by others may act similarly to OXT administration through enhanced secretion of endogenous OXT'. In line with this hypothesis, peripheral OXT levels have been associated with synchronized behavior in parent--infant bonds ([@nsx061-B25]; [@nsx061-B26]) and new lovers ([@nsx061-B60]). Interestingly, elevated OXT levels following experienced synchrony may induce a self-reinforcing loop by concomitantly increasing social synchrony. For instance, intranasal OXT has been found to modulate the neural response to highly synchronous stimuli ([@nsx061-B42]). Empirical evidence from a computerized drawing task further indicates that OXT administration improves cooperative performance ([@nsx061-B5]). In this task, coordination of behavior was required for cooperation and OXT selectively improved the synchronized performance of pairs, but had no effect on individual performance. Furthermore, a recent study reported that OXT increases rhythmical counting and the inter-brain coupling of alpha-band oscillations during a coordination task ([@nsx061-B47]). Regarding social emotion transmission, numerous studies have documented that intranasal OXT enhances emotion recognition from static ([@nsx061-B22]) and dynamic facial expressions ([@nsx061-B43]). Importantly, however, social communication relies not only on the precision of emotion recognition in perceivers but also on senders' ability to accurately convey their emotions. This bidirectional nature of social interactions points to a potential involvement of OXT in both the recognition and expression of emotions that has been largely neglected so far. [@nsx061-B69]) reported a positive correlation between cortisol-induced increases in plasma OXT levels and self-reported emotional expression. However, as yet, no study has directly examined the hormone's influence on the ability to facially or vocally express emotions. We propose here that social synchrony triggers the release of endogenous OXT, which in turn may improve bidirectional social emotion transmission by enhancing emotional expressiveness. This augmentation of affective sharing may subsequently contribute to better synchronized interactions, thus enabling the fine-tuning of social communication.

Experiment 1 of the present study was therefore aimed at determining whether social synchrony, operationalized as being imitated by another person, evokes the release of endogenous OXT in either the sender or the receiver of non-verbal signals. To control for the effect of mere social interaction, we randomly assigned 164 healthy participants (98 women) to a synchronous or an asynchronous interaction condition. In Experiment 2, we examined the influence of exogenously elevated OXT concentrations on emotion expression, as a core prerequisite of social communication. Thirty-five healthy male participants were recorded while producing facial and vocal expressions of happiness, fear and anger after intranasal administration of synthetic OXT (24 IU) and placebo (PLC). Subsequently, an independent sample of 106 women and men rated the salience of all emotional expressions. We hypothesized that (i) being imitated results in an increase of peripheral OXT levels and that (ii) elevated OXT levels foster the social transmission of emotions by enhancing the subject's emotional expressiveness.

Methods and results
===================

Ethics and enrollment
---------------------

The present study was approved by the local ethics committee of the Medical Faculty of the University of Bonn, Germany. All subjects gave their written, informed consent in accordance with the latest revision of the Helsinki Declaration.

Screening
---------

Enrollment in the experiments was preceded by sociodemographic data acquisition and clinical questionnaires. In Experiment 1, we administered the 'Saarbrücker Persönlichkeitsfragebogen', a German version of the Interpersonal Reactivity Index ([@nsx061-B16]). In Experiment 2, we assessed trait anxiety (State Trait Anxiety Inventory, STAI; [@nsx061-B66]), depressive symptoms (Beck Depression Inventory, BDI-II; [@nsx061-B9]), alexithymia symptoms (Toronto Alexithymia Scale, TAS; [@nsx061-B67]) and autistic-like traits (Autism-Spectrum Quotient; [@nsx061-B7]). Additionally, mood (The Positive and Negative Affect Schedule, PANAS; [@nsx061-B71]) and state anxiety (State-Trait Anxiety Inventory, STAI; [@nsx061-B66]) were measured at the start and end of each visit. Furthermore, we conducted a comprehensive psychological screening, ensuring that all subjects were free of any current or past physical or psychiatric illness as assessed by medical history and the Mini-International Neuropsychiatric Interview (MINI; [@nsx061-B62]). Moreover, subjects were naive to prescription-strength psychoactive medication and had not taken any over-the-counter psychoactive medication in the preceding four weeks.

Neuroendocrine parameter extraction
-----------------------------------

To asses peripheral OXT levels, all study participants were asked to submit two (Experiment 1) or three (Experiment 2) saliva samples throughout the testing session, using commercial sampling devices (Salivettes, Sarstedt). Salivettes were immediately centrifuged at 4000 rpm for 2 min and stored at -80 °C until assayed. Two additional saliva samples were obtained before and after task completion from participants of Experiment 2, to allow for a comprehensive assessment of peripheral cortisol levels.

Saliva OXT concentrations were extracted and quantified using a highly sensitive and specific radioimmunoassay (RIAgnosis, Munich, Germany) ([@nsx061-B32]).The limit of detection was 0.1--0.5 pg, depending on the age of the tracer. Intra-assay and inter-assay coefficients of variability were \< 10%. All samples to be compared were assayed in the same batch, i.e. under intra-assay conditions. Cortisol concentrations were determined using an electrochemiluminescence immunoassay (Elecsys Cortisol Test, Roche, Mannheim). The sensitivity of the assay was set at 0.054--63.4 μg/dl. The mean inter- and intra-assay coefficients of variation for the assays were 6.1% and 11.8%, respectively.

Statistical analysis
--------------------

Demographic, neuropsychological and behavioural data were analyzed using IBM SPSS Statistics 22 (IBM, New York, NY, USA). Main effects and interactions were identified via repeated measures analysis of variance (ANOVA) and paired *t*-tests. The assumption of sphericity was assessed with Mauchly's test and Greenhouse--Geisser's correction was applied for significant violations. Pearson's chi-squared tests were used for qualitative variables. Correlation analyses were performed via Pearson's product-moment correlation. Due to the directed hypothesis, we applied one-tailed *P*-values in Experiment 1, expecting increased OXT levels after synchronous interaction. Having less clear hypotheses regarding the effect of intranasal OXT on the various facets of emotional expression we applied two-tailed *P*-values in Experiment 2. All reported *P*-values are corrected for multiple testing, using the Bonferroni correction method. Effect sizes are given as measures of Eta-squared and Cohen's *d*.

Experiment 1
------------

In Experiment 1, we wanted to examine whether synchronous interactions elicit OXT release in dyadic pairs of participants compared with asynchronous interactions. Facing each other, one participant ('sender') made hand gestures, while the other ('receiver') was either instructed to mirror these gestures (synchronous condition) or to perform different gestures (asynchronous condition).

### Methods

#### Subjects and protocol

One hundred sixty-four healthy volunteers participated in the study after giving their written, informed consent. Saliva samples were not available for five participants. Thus, the data from 159 participants (98 women; mean age ± SD: 21.84 ± 2.94 years) were analyzed. Sixty-four women were using hormonal contraception.

#### Design and procedure

All participants were tested in groups, which were then randomly assigned to either a synchronous (*n* = 90) or an asynchronous interaction condition (*n* = 69). There were no a priori differences between participants in the synchronous and asynchronous conditions (cf. [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). In the synchronous condition, random pairs of participants were instructed to perform a synchronous non-verbal interaction task for 5 min. Actor A (i.e. the sender) made hand gestures and Actor B (i.e. the imitator or receiver) mirrored these hand gestures. Before the experiment, short videos of five different hand gestures were shown to the participants who could choose any of these hand gestures to imitate (moving the right hand to the left ear, moving the right hand to the head, turning the head, turning the hands or moving the right hand towards the other actor). To facilitate the imitation, each hand gesture was repeated five times before a new hand gesture could be presented in the interaction task. In the asynchronous interaction, Actor B was instructed to make hand gestures that were different from the hand gestures shown by Actor A. All participants were asked to keep a neutral facial expression during the interaction task. After the task, all participants rated the likeability of the interaction partner on a Likert scale (1 = very unlikable; 7 = very likeable). In the synchronous condition, Actor A also rated the quality of the imitation (1 = very low; 7 = very high). Saliva samples were collected at the start (i.e. before the task) and after completion of the dyadic interaction (i.e. after the task).

### Results

A repeated measures ANOVA with 'time point of saliva sampling' (before the task, after the task) as within-subject factor, 'synchrony' (synchronous, asynchronous), 'actor' (sender, receiver) and 'use of hormonal contraception' (hormonal contraception use, freely cycling) as between-subject variables, and the salivary OXT concentration as dependent variable revealed a significant interaction of 'time point' and 'synchrony' (*F*~(1,\ 151)~ = 5.55, *P* = 0.02, η^2^ = 0.04), but no further main or interaction effects. Post hoc paired *t*-tests revealed that the synchronous interaction evoked the release of endogenous OXT (sender: *t*~(42)~ = 2.19, *P* = 0.04, *d* = 0.13; receiver: *t*~(47)~ = 1.91, *P* = 0.06, *d* = 0.27; cf. [Figure 1A](#nsx061-F1){ref-type="fig"}), while there was no effect in the asynchronous condition (*P* ≥ 0.41). In fact, the number of participants who showed an increase in OXT concentration (\> 0 pg/ml) during the task was significantly larger in the synchronous than in the asynchronous condition (*χ*^2^~(1)~ = 11.12, *P \< *0.01, cf. [Figure 1B](#nsx061-F1){ref-type="fig"}). This pattern of results did not change when we included gender as an additional between-subject variable (cf. [Supplementary Information](#sup1){ref-type="supplementary-material"}). The likability ratings of the interaction partner were comparable between the synchronous and the asynchronous conditions (*t*~(157)~ = 0.59, *P* = 0.56, *d* = 0.09). Furthermore, there was no association between likeability and imitation quality ratings and OXT concentrations (before the task, after the task or in the difference 'after minus before'; all *P*s ≥ 0.14).

![Effect of imitation on endogenous oxytocin concentrations. The imitation of hand gestures induced the release of endogenous oxytocin (OXT) in both the sender and the receiver (i.e. imitator) of synchronously interacting dyads (A). Likewise, the majority of subjects in synchronous dyads (*n* = 90) showed an increase of salivary OXT concentrations during the imitation (B). There was no significant change in the OXT concentrations of non-synchronous dyads (*n* = 69). Error bars indicate the standard error of the mean (SEM). OXT, oxytocin; Pre, before imitation; Post, after imitation. \**P* \< 0.05, ^\#^*P* \< 0.10.](nsx061f1){#nsx061-F1}

Collectively, we demonstrate increased OXT release after synchronous but not asynchronous interactions in both the sender and receiver of non-verbal signals, which was not driven by differences in gender, likability or imitation quality.

Experiment 2
------------

In Experiment 1 we showed that synchrony increases peripheral OXT levels; in Experiment 2 we wanted to follow up and ask whether increased OXT levels then impact social--emotional communication. Here we moved to an experimental paradigm to elucidate causal effect of heightened OT on emotion expression in the sender of social information. To this end, we separately recorded male participants while they expressed happy, fearful, and angry facial and vocal expressions. All senders conducted the emotion expression task twice on two different days, after having received OXT or PLC, respectively (see 'Emotion expression recording'). An independent sample of receivers rated the emotional intensity by quantifying the intensity of happiness, fear and anger they perceived in every expression (see 'Emotion expression rating').

### Methods

#### Emotion expression recording

*Subjects and protocol* **.** The expression task included 35 healthy male senders. Following a double-blind, placebo-controlled, within-subject design, participants performed the emotion expression task twice (once after intranasal OXT and once after intranasal PLC administration). The order of OXT and PLC application was randomized across testing days and the mean latency between application of treatment and task onset was 52 min. During the waiting time, senders filled out questionnaires and participated in an unrelated task. Study appointments were scheduled at least 24 h apart. Data from three subjects were lost due to technical problems, resulting in a final sample size of 32 participants (age: 24.5 ± 4.1 years).

*Intranasal treatment* ***.*** Participants self-administered nasal sprays containing either synthetic OXT or PLC at the beginning of the testing session. The administration instructions were in accordance with the latest standardization guidelines ([@nsx061-B29]) and administration was supervised by a trained research assistant. Participants received an OXT dose of 24 IU (three puffs per nostril, each with 4 IU OXT). The synthetic OXT and the PLC solutions were provided by Sigma-Tau Pharmaceuticals, Inc. (Pomezia, Italy). The PLC solution contained the identical ingredients except for the peptide itself.

Accumulating evidence indicates that intranasal OXT leads to elevated OXT concentrations in the cerebrospinal fluid (CSF) in macaques ([@nsx061-B15]; [@nsx061-B41]) and humans ([@nsx061-B63]). CSF penetration by intranasal OXT may be much lower than penetration into the cerebral tissue, as only a small fraction of intranasal OXT reaches the CSF, where it has to accumulate (over 60--75 min) in order to produce a signal ([@nsx061-B41]; [@nsx061-B63]). Experiments in mice have shown that intranasal OXT quickly permeates into specific areas of the brain ([@nsx061-B65]), thus underlining OXT's central mode of action ([@nsx061-B33]) and the utility of intranasal OXT as a pharmacological means to alter central OXT signaling.

*Task procedure* ***.*** The emotion expression task comprised two runs, requiring emotion expression in the facial and vocal modalities, respectively. Specifically, participants were recorded while producing angry, fearful and happy facial expressions (with a neutral face in between emotions) and vocalizing pseudowords with angry, fearful, happy and neutral prosodies on demand. Randomly presented, one-word instructions on a computer screen indicated the emotion to be expressed next, complemented by a disyllabic pseudoword to be read aloud in the prosody condition. The here used pseudowords (i.e. phonologically legal but semantically meaningless letter strings, such as 'hultin' or 'galeng') were retrieved from the validated test battery TEPP© ([@nsx061-B73]; [@nsx061-B72]). Stimuli from the TEPP© have already been applied in multiple experimental and clinical studies on prosody ([@nsx061-B24]; [@nsx061-B53]; [@nsx061-B68]). Two beeps of defined audible frequencies (one sharp and one deep tone) 3 s apart marked the start and end of an emotional expression. The interstimulus interval between emotional expression and instruction was 3 s. To prevent interference between two consecutively displayed facial expressions, non-emotional control blocks (yawning, opening and closing one's mouth, puffing one's cheeks) were alternated with the emotions of interest, but were not further considered in the analysis. The vocal and facial expressions were recorded twice. The first expression served as a practice trial to prevent confounds due to surprise or inattention effects. Thus, only the second emotion expression was further processed and evaluated by the independent sample of raters. The order of trials was randomized across all subjects in both the facial and vocal recording conditions. Facial expressions were recorded via a camcorder (SONY HD-Camcorder HXR-MC2000E) that constantly filmed the sender from the shoulders up against a grey backdrop. Senders were asked to directly face the camera after the presentation of instructional cue words. Vocal expressions were recorded using a high quality recording device, with the microphone placed 5 cm away from senders' mouths. During all recordings, senders were alone in the testing room and sat on a fixed chair.

Each run lasted ∼7 min, resulting in a total task duration of 14 min. Finally, senders were asked to rate their stress levels during the recording procedure on a scale ranging from 0 ('not at all stressful') to 10 ('very stressful') and to guess whether they had received OXT or PLC at the current testing day. Saliva samples were collected before nasal spray administration (baseline), and at the start and after completion of the emotion expression task.

*Data processing* ***.*** After completion of the experiment, a blinded assistant who was not involved in the experiments evaluated the video and audio recordings for recording quality and processed them with iMovie (Version 10.0.5) on a Mac G5 tower running OSX 10.9, resulting in single, 3-s long video/audio files for each emotion expression. Videos were standardized in height and width and adjusted to comparable brightness. Audio files were adjusted to comparable volume. This standardized editing procedure eventually resulted in a final stimulus pool of 256 facial and 256 vocal expressions (128 taken after OXT and 128 after PLC administration).

Emotion expression ratings
--------------------------

***Subjects*** ***.*** For the subsequently conducted emotional expressions ratings, we recruited an independent sample of 106 subjects (referred to as 'receivers' from here on). All receivers were randomly assigned to quantify the emotional intensity of either vocal or facial expressions. Five subjects had to be excluded from analysis as they failed to complete the task. Thus, the final sample comprised 56 receivers for the facial expressions (21 male, 25.42 ± 4.22 years) and 45 receivers for vocal expressions (22 male, 25.67 ± 4.36 years). There were no a priori differences between sender and receiver samples (cf. [Supplementary Table S2](#sup1){ref-type="supplementary-material"}).

***Rating procedure*** ***.*** All receivers read standardized instructions that explained the rating procedure and were then seated in front of a computer screen. Receivers assigned to judge vocal expressions were additionally equipped with noise-canceling headphones. In each of the 256 randomly ordered trials (32 senders displaying four emotions; once after OXT, once after PLC treatment), receivers saw or heard one of the previously recorded happy, fearful, angry or neutral expressions. After each trial, participants were asked to quantify the intensity of happiness, fear and anger in the precedent emotion expression using visual analogue scales ranging from 1 (minimal intensity) to 100 (maximal intensity). Hence, the final data pool for each receiver consisted of three intensity ratings per stimulus (e.g. for happy expressions there was one intensity rating for the instructed emotion category, happiness, and two for the remaining alternative categories).

***Results*** ***.*** To evaluate the impact of the intranasal OXT administration on facial expressiveness, we computed a repeated measures ANOVA with 'senders' emotion' (happy, fearful and angry) and 'senders' treatment' (OXT, PLC) as within-subject factors and the 'mean intensity rating for the depicted *facial* emotion' as dependent variable. This ANOVA yielded main effects of 'senders' emotion' (*F*~(2,\ 110)~ = 70.67, *P* \< 0.01, η^2^ = 0.56) and 'senders' treatment' (*F*~(1,\ 55)~ = 5.23, *P* = 0.03, η^2^ = 0.09) as well as a significant interaction of both factors (*F*~(2,\ 110)~ = 14.91, *P* \< 0.01, η^2^ = 0.21; cf. [Figure 2A](#nsx061-F2){ref-type="fig"}). Post hoc comparisons revealed that OXT enhanced the emotional intensity of expressions of happiness (*t*~(55)~ = 4.5, *P* \< 0.01, *d* = 0.16) and fear (*t*~(55)~ = 3.32, *P* \< 0.01, *d* = 0.11), whereas angry expressions were perceived as less intense after OXT administration (*t*~(55)~ = -2.91, *P = *0.02, *d = *-0.14).

![Effects of elevated oxytocin levels on the salience of facial and vocal emotional expressions. Following the intranasal administration of oxytocin (OXT; 24 IU) or placebo (PLC), 32 male participants (senders) were instructed to produce facial and vocal expressions of anger, fear and happiness. Two independent samples of women and men (receivers, *n* = 56 and *n* = 45) rated the intensity of the facial and vocal expressions. OXT enhanced the perceived intensity of happy and fearful facial expressions but reduced the perceived intensity of the facial display of anger (A). In the auditory domain, OXT increased the emotional expressions' intensity unequivocally across valences (B). Error bars indicate the standard error of the mean (SEM). OXT, oxytocin; PLC, placebo. \**P* \< 0.05, \*\**P* \< 0.01.](nsx061f2){#nsx061-F2}

A repeated measures ANOVA with the 'mean intensity rating for the depicted *vocal* emotion' as the dependent variable also showed main effects of 'senders' emotion' (*F*~(2,\ 88)~ = 43.14, *P* \< 0.01, η^2^ = 0.50) and 'senders' treatment' (*F*~(1,\ 44)~ = 52.07, *P* \< 0.01, η^2^ = 0.54) as well as a significant interaction effect (*F*~(2,\ 88)~ = 7.6, *P* = 0.01, η^2^ = 0.15; cf. [Figure 2B](#nsx061-F2){ref-type="fig"}). In contrast to facial expression, OXT treatment led to increased intensity of vocal expressions in all emotion categories. However, this effect was more pronounced for angry expressions (*t*~(44)~ = 6.64, *P \< *0.01, *d* = 0.39) than for fearful (*t*~(44)~ = 3.51, *P* \< 0.01, *d* = 0.18) or happy (*t*~(44)~ = 2.64, *P* = 0.03, *d* = 0.13) expressions (for details on task validation and emotion-specific recognition patterns see [Supplementary Figure S1](#sup1){ref-type="supplementary-material"} and [Supplementary Information](#sup1){ref-type="supplementary-material"}). Treatment had no effect on subjective stressfulness ratings or cortisol levels as a surrogate marker of stress axis activity (for details see [Supplementary Information](#sup1){ref-type="supplementary-material"}).

Collectively, our results provide evidence for a key role of OXT in modulating emotional expressiveness. Specifically, OXT increased the intensity of expression of happiness and fear across sensory modalities, while differentially modulating angry expressions.

Discussion
==========

In accordance with our initial hypotheses, in Experiment 1 we found that the experience of social synchrony evokes the release of endogenous OXT in both the sender and the receiver of non-verbal signals. Intriguingly, the results of Experiment 2 indicate that heightened OXT levels enhance emotion transmission of social information. Specifically, intranasal OXT made signals of happiness and fear more salient in both facial and vocal expressions. Thus, OXT seems to augment the sender's expressiveness, yielding a bidirectional enhancement of social communication.

Overall, our findings point to a central role of social synchrony in facilitating reciprocal communication between individuals via heightened OXT signaling. By means of a bio-behavioral feedback loop, elevated OXT levels among highly synchronized interacting partners may contribute to a bidirectional refinement of emotion transmission, which in turn yields further interpersonal synchronization and concomitant OXT release in both the sender and the receiver of social information. How can enhanced emotional expressiveness promote social synchrony? First, more salient facial and vocal expressions of emotions facilitate the communication of nuanced information about the nature of any dyadic relationship ([@nsx061-B49]). Affective displays convey information about the sender's underlying motives and character ([@nsx061-B1]) and modulate the likelihood of cooperation ([@nsx061-B12]). Second, built on mechanisms of simulation and embodiment ([@nsx061-B48]), more pronounced expressiveness may support vicarious emotional responding. Thus, it seems likely that the improved transmission of emotional signals may foster coordinated behavior in both timing and form ([@nsx061-B23]). Collectively, our results highlight the involvement of the oxytocinergic system in this circular amplification of dyadic attunement, which may also explain why synchrony can increase cooperation ([@nsx061-B74]).

Our observation of increased OXT levels after synchronous, but not asynchronous, interaction in Experiment 1 is congruent with the finding that intranasal OXT enhances automatic imitative behavior ([@nsx061-B17]) and supports the notion that OXT mediates the effects of imitation on social behavior ([@nsx061-B4]). Accordingly, heightened generosity ([@nsx061-B70]) and visual preference or affiliative behaviors towards an imitating person ([@nsx061-B27]) may thus depend on increased OXT secretion in the imitated person. In fact, it has been reported that a social interaction pretreatment has a similar effect as the intranasal administration of OXT on the processing of negative emotional faces ([@nsx061-B37]). Against this background, therapeutic interventions fostering imitation or synchronization in general ([@nsx061-B38]), may constitute an efficient non-pharmacological probe to increase OXT levels and improve social skills.

While numerous studies have documented that intranasal OXT enhances emotion recognition from both static ([@nsx061-B22]) and dynamic facial expressions ([@nsx061-B43]), evidence for an effect of OXT on emotion expression generation has been scarce to date. Here, we demonstrate OXT's positive influence on expressiveness in the facial and vocal domains. These findings resonate well with previous observations that individual differences in the OXT receptor gene are associated with behavioral manifestations of prosociality ([@nsx061-B39]) and that cortisol-induced increases in plasma OXT levels correlate with self-reported emotional expressiveness ([@nsx061-B69]). Of note, the observed OXT effect on the expression of happiness and fear is also remarkably congruent with the OXT effect on emotion recognition. A recent meta-analysis concluded that OXT specifically affects the recognition accuracy of happiness and fear ([@nsx061-B61]). In contrast to anger expressions, both happy and fearful facial expressions elicit approach behavior ([@nsx061-B44]). As such, the enhancing effect of OXT on happy and fearful expressions in both the facial and vocal domain lends further support to theoretical models assuming that OXT facilitates approach behavior ([@nsx061-B34]). An alternative explanation for the increased intensity of facial expressions might be that the neuropeptide facilitates the control of facial muscles. However, the fact that OXT produced similar effects in the vocal domain speaks against a simple muscular mechanism and rather points to global effects of OXT on emotional expressiveness.

OXT thus seems to attenuate the ambiguity of emotional expressions, thereby enhancing the salience, and reducing uncertainty about the predictive value, of communicative signals ([@nsx061-B45]). An improved signal-to-noise ratio in emotion transmission under conditions of OXT-mediated social synchrony may lie at the core of feelings of closeness and familiarity. This notion has strong implications for a wide range of social settings and contexts, ranging from gestures of encouragement in team sports and the communication of empathic concern during patient--caregiver interactions to attachment bonds between parents and infants. For instance, we have previously shown that OXT promotes the romantic bond between men and women by enhancing reward system responses to the partner's face ([@nsx061-B59]; [@nsx061-B56]). Findings that marital satisfaction positively correlates with emotional expressiveness ([@nsx061-B35]), could thus be driven in part by an OXT-induced increase in behavioral synchrony between partners in addition to other changes in communicative style ([@nsx061-B21]; [@nsx061-B20]).

Several aspects of our study deserve further comment. First, only male participants were tested in Experiment 2. As a substantial body of evidence now points to sexual-dimorphic effects of OXT ([@nsx061-B52]; [@nsx061-B55]; [@nsx061-B58]), we cannot extrapolate our findings to women. Therefore, future studies are warranted to replicate the current findings in women and explore possible interactions with gonadal steroids. Second, in the present study, we focused on instructed imitation and posed expressions. It remains to be determined how spontaneous social synchrony affects OXT levels in the sender and receiver and whether the effects of OXT are comparable between spontaneous and instructed production of emotion expressions ([@nsx061-B46]). Third, we applied a consecutive study design to standardize the social imitation and interaction and did not assess emotion transmission in a real-life setting.

In conclusion, we here propose a comprehensive model that sheds new light on the role of the OXT signaling in mediating emotion transmission between individuals by facilitating communicative reciprocity. In the presence of social synchrony, OXT may enhance the salience of emotional expressions towards an interacting partner, thus improving the signal-to-noise ratio in social communication and promoting social cohesion.
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